A Q&A With Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research.
at the Food and Drug Administration, Woodcock is responsible for making sure that new medicines are safe and effective before they can be prescribed to patients or sold directly to consumers. Her staff reviews thousands of applications for new and generic drugs per year.
Woodcock will be a keynote speaker Friday evening at the Breakthroughs in Medicine conference in Rancho Palos Verdes. She spoke with The Times about the country’s most pressing health problems and what the FDA is doing about them.We watch over all of the drugs: generic drugs, over-the-counter drugs, the ones you get with a prescription. We make sure they’re safe and effective, and decide whether they can be put on the market.
Plus nicotine addiction, in all its phases. We’ve approved a lot of products to help people get off of it. But there’s a concern that many more young people are being exposed through vaping, which can lead to addiction to nicotine. Overuse of antibiotics has fueled the growth of drug-resistant superbugs. What can the FDA do about that?
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New research shows an AI-powered system can develop potential new drugs in just 3 weeksInsilico Medicine published research that proves its artificial intelligence system is capable of developing potential new drugs in 21 just days.
Read more »
Kelly Clarkson on Country Music: ‘Y’all Don’t Play People With Boobs’Singer decries stylistic changes, lack of women in contemporary country during Q&A for new talk show
Read more »
Future helicopters will fly in new waysWhat will helicopters look like in the future?
Read more »
Texas Doctor Stephen M. Hahn Is a Top Contender to Head FDAThe radiation oncologist at M.D. Anderson Cancer Center in Houston has emerged as a top candidate to be nominated by the Trump administration to become commissioner of the Food and Drug Administration.
Read more »
Dow futures trade slightly higher ahead of jobs dataU.S. stock index futures traded slightly higher on Friday as investors looked ahead to nonfarm payroll numbers due later in the day.
Read more »